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Hsp70/Hsp90-organizing protein (Hop)1 (1, 2) and mSTI1 (3,
4) are homologous members of the stress-inducible protein 1
(STI1) family of co-chaperones. mSTI1 has 97% amino acid
identity with Hop (4). Hop functions at an intermediate stage of
the assembly of progesterone receptor by acting as an adaptor
protein between Hsc70 and Hsp90 to form a multichaperone
complex (2, 5). Both Hop and mSTI1 interact with Hsc70 and
Hsp90 via their N-terminal and first central tetratricopeptide
repeat domains, respectively (3, 6). The so-called tetratricopeptide repeat (TPR) motif is a degenerate 34-amino acid sequence
that has been recruited by a significant number of co-chaperones that interact especially with Hsp90 (7–16). It is often
found in multiple copies and in tandem array in proteins (17,
18). A typical TPR motif consists of two anti-parallel ␣ helices
with small consensus hydrophobic residues occurring at position of closest contact between the helices whereas large consensus residues are usually found at interfaces between adjacent helices in a tandem array (17–19). In multiple-motif TPR
proteins, tandem TPR motifs fold into a right-handed superhelical structure forming a binding groove to accommodate
partner proteins (19). Experimental evidence suggests that
conserved basic residues that project into the grooves of the
TPR domains of proteins that interact with Hsc70 and Hsp90
are important for binding to these molecular chaperones (20).
The crystal structures of the N-terminal TPR domain (TPR1)
of Hop in complex with the C-terminal heptapeptide of Hsp70
and the first central TPR domain (TPR2A) in complex with the
C-terminal pentapeptide of Hsp90 have been determined (6).
The structures predict that binding involves a network of electrostatic interactions between charged amino acid residues in
the N-terminal and first central TPR domains of Hop and the
C-terminal EEVD motifs of Hsp70 and Hsp90 peptides, respectively. Recently, it has been shown that, whereas Asp0 and
Val⫺1 act as general anchor residues, the highly conserved
glutamates of the EEVD motif, which appear to be critical in
Hsp90 binding by TPR2A, do not contribute appreciably to the
interaction of Hsp70 with TPR1 (21). The electrostatic interactions between the TPR domains and the C-terminal aspartate
(Asp0) form a two-carboxylate clamp that appears to be necessary for binding of Hop to Hsp70 and Hsp90. Residues in the
TPR1 domain predicted to be involved in forming this clamp
include Lys8, Asn12, Asn43, Lys73, and Arg77, whereas the topologically equivalent residues in the TPR2A domain are
Lys229, Asn233, Asn264, Lys301, and Arg305. These amino acid
1
The abbreviations used are: Hop, Hsp70/Hsp90-organizing protein;
GST, glutathione S-transferase; TPR, tetratricopeptide repeat; PBS,
phosphate-buffered saline; PMSF, phenylmethylsulfonyl fluoride; STI1,
stress-inducible protein 1.
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Murine stress-inducible protein 1 (mSTI1) is a cochaperone that is homologous with the human Hsp70/
Hsp90-organizing protein (Hop). Guided by Hop structural data and sequence alignment analyses, we have
used site-directed mutagenesis, co-precipitation assays,
circular dichroism spectroscopy, steady-state fluorescence, and surface plasmon resonance spectroscopy to
both qualitatively and quantitatively characterize the
contacts necessary for the N-terminal tetratricopeptide
repeat domain (TPR1) of mSTI1 to bind to heat shock
cognate protein 70 (Hsc70) and to discriminate between
Hsc70 and Hsp90. We have shown that substitutions in
the first TPR motif of Lys8 or Asn12 did not affect binding of mSTI1 to Hsc70, whereas double substitution of
these residues abrogated binding. A substitution in the
second TPR motif of Asn43 lowered but did not abrogate
binding. Similarly, a deletion in the second TPR motif
coupled with a substitution of Lys8 or Asn12 reduced but
did not abrogate binding. These results suggest that
mSTI1-Hsc70 interaction requires a network of interactions not only between charged residues in the TPR1
domain of mSTI1 and the EEVD motif of Hsc70 but also
outside the TPR domain. We propose that the electrostatic interactions in the first TPR motif made by Lys8 or
Asn12 define part of the minimum interactions required
for successful mSTI1-Hsc70 interaction. Using a truncated derivative of mSTI1 incapable of binding to Hsp90,
we substituted residues on TPR1 potentially involved in
hydrophobic contacts with Hsc70. The modified protein
had reduced binding to Hsc70 but now showed significant binding capacity for Hsp90. In contrast, topologically equivalent substitutions on a truncated derivative
of mSTI1 incapable of binding to Hsc70 did not confer
Hsc70 specificity on TPR2A. Our results suggest that
binding of Hsc70 to TPR1 is more specific than binding
of Hsp90 to TPR2A with serious implications for the
mechanisms of mSTI1 interactions with Hsc70 and
Hsp90 in vivo.

Hsc70-mSTI1 Interaction

EXPERIMENTAL PROCEDURES

General Procedures—General molecular biology procedures such as
restriction enzyme digestion, agarose gel electrophoresis, ligation, preparation of competent bacterial cells, and bacterial cell transformation
were done according to standard protocols (22). Protein concentrations
were determined using the Bradford protein assay (23). SDS-PAGE was
performed according to Laemmli (24) and Western blotting according to
Towbin et al. (25). The enhanced chemiluminescence system (ECL;
Amersham Biosciences) was used to detect specific proteins during
Western analysis.
Oligonucleotide-directed Mutagenesis—All mutations were generated from the plasmids pGEX3X2000 and pQE30 –2000, which contain
the cDNAs encoding the full-length proteins GST-543 and His-543,
respectively. Generation of the deletion plasmids pGEX3X700 (encoding GST fusion of the C-terminal truncated protein, GST-N217),
pGEX3X1400 (encoding GST fusion of the N-terminal truncated protein, GST-C334), and pGEX3X2000 (⌬37– 47) (encoding GST fusion of
the protein in which residues 37– 47 have been deleted, GST-543 (⌬37–
47)) has been previously reported (3, 26). All mutations were carried out
by site-directed mutagenesis using a double-stranded whole plasmid
linear amplification procedure (QuikChange mutagenesis kit; Stratagene, La Jolla, CA). Silent mutations were engineered to create restriction sites for screening purposes except where the desired codon

change(s) automatically generated restriction sites. The following alanine (Ala) mutant proteins were generated: GST-543 (K8A), GST-543
(N12A), GST-543 (K8A,N12A), His-543 (K8A,N12A), GST-543 (N43A),
GST-543 (⌬37– 47, K8A), GST-543 (⌬37– 47, N12A), and GST-543
(K301A). GST-543 (Y27A) was generated as previously described (26).
In the deletion mutant, a highly conserved block of amino acids in helix
2A (residues 37– 47) was deleted. Other mutants generated are: GSTN217 (L15Y), GST-N217 (A49F,K50E), GST-N217 (L15Y,A49F,K50E),
GST-C334 (Y236L), GST-C334 (F270A,E271K), and GST-C334
(Y236L,F270A,E271K). All mutations were confirmed both by restriction enzyme analysis and by DNA sequencing using the ABI PRISM
3100 Genetic Analyzer.
Production and Purification of GST-mSTI1 Fusion Proteins—Exponentially growing Escherichia coli XLI Blue cells carrying pGEX3Xderived plasmid constructs were induced for 5– 6 h at 37 °C with 1 mM
isopropyl-1-thio-␤-D-galactopyranoside. The cells were harvested and
lysed by mild sonication in 0.01 culture volume of ice-cold phosphatebuffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4
mM KH2PO4, pH 7.3) containing 1 mM final concentration of phenylmethylsulfonyl fluoride (PMSF). The sonicate was incubated, with gentle agitation, for 30 min at room temperature after addition of Triton
X-100 to 1% final concentration. The extracts were clarified by centrifugation at 12,000 ⫻ g for 20 min at 4 °C. Aliquots of clarified extracts
were added to 50% (w/v) slurry of glutathione-agarose beads (2-ml bed
volume per 100 ml of extract) previously equilibrated with PBS. Binding was allowed to occur for 1 h at 4 °C with gentle rocking. After the
beads were washed extensively with ice-cold PBS, the bound GST
fusion proteins were eluted by adding appropriate volume of the elution
buffer (10 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0). Eluted
GST fusion proteins were analyzed by 12% SDS-PAGE. Both wild-type
and mutant proteins were expressed easily and found to be soluble.
Production and Purification of His6-tagged mSTI1 Proteins—Heterologous production of His6-tagged mSTI1 proteins in exponentially
growing E. coli cells was induced by 1 mM isopropyl-1-thio-␤-D-galactopyranoside. The E. coli cells were treated and lysed as described above.
The clarified lysate was loaded onto a nickel-nitrilotriacetic acid resin
column. Washing of the column was done using a buffer containing 50
mM Na2HPO4, pH 7.5, 20 mM imidazole, and 1 mM PMSF. The protein
was eluted with a linear gradient of 20 –300 mM imidazole. The ligand
was removed from the protein by gel filtration in a Sephadex G-25
column. Buffer exchange was achieved by loading the purified protein
onto a hydroxyapatite column previously equilibrated with 20 mM
K2HPO4, pH 7.5, and eluting with a linear gradient of 20 –300 mM
K2HPO4. The homogeneity of the protein was assessed by SDS-PAGE
(12%) and size exclusion-high performance liquid chromatography using a LKB model 2150.
Glutathione-Agarose Co-precipitation Assays—In separate 1-ml reactions, GST-mSTI1 fusion proteins were coupled to glutathione-agarose
beads to a final concentration of 0.3 M. Binding was allowed to occur
for 1 h at 4 °C, after which unbound fusion protein was removed by
washing three times in ice-cold PBS. Hsc70 binding assays were conducted by incubating the coupled agarose beads with 250 g of NIH 3T3
crude extracts in a 1-ml reaction volume using ice-cold PBS. In Hsp90
binding assays, purified Hsp90 rather than extract proteins was added
to a final concentration of 0.025 M. After incubation for 2 h at 4 °C, the
beads were collected and washed extensively in ice-cold PBS to remove
nonspecifically bound extract proteins. The bound proteins were solubilized in 70 l of SDS sample buffer and 30 l analyzed on a 12%
SDS-PAGE. After transferring onto nitrocellulose membrane, co-precipitation of Hsc70 or Hsp90 with the GST-mSTI1 fusion proteins was
revealed by immunodetection and chemiluminescent autoradiography
using the monoclonal primary antibodies H5147 and H9010 specific for
Hsc70 and Hsp90, respectively.
Surface Plasmon Resonance Spectroscopy—Surface plasmon resonance spectroscopy was performed using a Biacore X apparatus. All
experiments were performed at 25 °C in PBS containing 0.005% P20
surfactant (buffer A). Monoclonal goat anti-GST antibody was covalently attached to carboxymethlylated dextran on a sensor chip CM5
via amine coupling according to the protocol from the manufacturer
(Biacore AB, Uppsala, Sweden). Approximately 700 response units of
GST-mSTI1 fusion protein were bound to the immobilized antibody.
Recombinant GST was immobilized on a separate reference flow cell.
The chip was equilibrated with buffer A before passing solutions containing increasing concentrations of purified Hsc70 or Hsp90 over the
bound proteins at a flow rate of 10 l/min. For competition experiments,
mixture of full-length Hsc70 and Hsp90 (8 and 5 M final concentrations, respectively) was pre-incubated at 25 °C before passing it over the
immobilized mSTI1 proteins. Background binding to GST was sub-
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residues are highly conserved in TPR-containing proteins that
bind to the C-terminal EEVD motifs of Hsc70 and Hsp90.
Discrimination between the C termini of the two molecular
chaperones appears to depend largely on hydrophobic and van
der Waals interactions between residues in the TPR domains of
Hop and residues upstream of the EEVD motif (6, 21). For
example, Ala46, Ala49, and Lys50, all in helix A of the second
TPR motif (helix 2A) in TPR1 of Hop, make hydrophobic contacts with the isoleucine (Ile⫺4) of the IEEVD sequence in
Hsp70, whereas Tyr236 and Glu271 in helix A of the first TPR
motif (helix 1A) and helix A of the second TPR motif (helix 2A)
of TPR2A, respectively, make important hydrophobic contacts
with the methionine (Met⫺4) of the MEEVD sequence in
Hsp90. Pro⫺6, which is further upstream of the EEVD motif in
Hsp70, exists in a hydrophobic cavity formed by Glu83 and
Phe84 of helix A of the third TPR motif (helix 3A) in TPR1.
Val⫺1 in the EEVD motif of Hsp70 makes hydrophobic contacts
with Asn12 and Leu15 in helix 1A and with Asn43 in helix 2A of
TPR1. In the TPR2A complex, Val⫺1 in the EEVD motif of
Hsp90 is in hydrophobic contacts with Asn233, Asn264, and
Ala267.
The relevance of the individual amino acids in the C-terminal peptides of Hsp70 (PTIEEVD) and Hsp90 (MEEVD) to the
Hsp70-Hop-Hsp90 complex, and in particular the Hsp90-Hop
complex, has been characterized (21). However, the relative
significance of the individual amino acids in the TPR1 domain
groove to general binding and specificity of the Hsp70-Hop
complex has yet to be experimentally characterized. Using
site-directed mutagenesis, co-precipitation assays, circular dichroism spectroscopy, steady-state fluorescence, and surface
plasmon resonance spectroscopy, we provide both qualitative
and quantitative evidence to show that mSTI1-Hsc70 interaction requires a network of interactions not only between
charged residues in the TPR1 domain of mSTI1 and the EEVD
motif of Hsc70, but also outside the TPR domain. We also
propose that the electrostatic interactions in the first TPR
motif made by Lys8 or Asn12 define part of the minimum
interactions required for successful mSTI1-Hsc70 interaction.
Furthermore, we provide evidence that hydrophobic contacts in
the second TPR motif of TPR1 domains are important in determining specificity of mSTI1 interaction with Hsc70, and by
doing amino acid substitutions, we have engineered the ability
to bind Hsp90 on the Hsc70-specific TPR1 domain of mSTI1. In
contrast, engineering Hsc70-binding capacity on the Hsp90binding TPR2A was not possible by simple swapping of topologically equivalent residues.
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tracted from each signal to account for nonspecific binding to GST. Data
were analyzed using the BIAevaluation software version 2.2.4.
Spectroscopic Measurements—Fluorescence emission spectra and
other fluorescence measurements were made at 25 °C in 20 mM sodium
phosphate, 1 mM EDTA, pH 7.5. The intrinsic fluorescence (excitation
at 295 nm) of the lone tryptophan in mSTI1 was measured for 2 M
protein between 300 and 400 nm in a PerkinElmer fluorescence spectrophotometer (27). Circular dichroism measurements were made using
8 M amounts of each protein sample in a Jasco J-710 spectropolarimeter. Ellipticity values were collected (average of 10 runs) in both the
near-UV (350 –250 nm) and far-UV (250 –200 nm) regions.
NIH 3T3 Cell Culture and Preparation of Cell Lysates—NIH 3T3
mouse fibroblast cells were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum and 1% penicillin (100
units/ml)/streptomycin (100 g/ml) solution, at 37 °C and 10% CO2 until
they reached 80 –100% confluence. The cells were harvested by
trypsinization followed by three washes with PBS. The harvested cells
were resuspended in appropriate volume of lysis buffer (50 mM TrisHCl, 150 mM NaCl, 0.02% sodium azide, 100 g/ml PMSF, 1 g/ml
aprotinin, and 1% Triton X-100) and incubated at 4 °C for 10 min to
allow lysis to occur. The lysate was centrifuged at 12,000 ⫻ g for 30 min
at 4 °C, and the supernatant used immediately.
RESULTS
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Residues in TPR Domains of mSTI1 Required for Binding the
EEVD Motif Are Highly Conserved in Homologous TPR Domains—Fig. 1A shows the various GST-mSTI1 protein derivatives used in this study. For both steady-state and circular
dichroism spectroscopies, we used the His6-tagged proteins. We
constructed a sequence alignment of Hsc70-interacting TPR
domains of STI1 homologues. The alignment revealed that the
charged residues in the TPR domains predicted to form the
so-called two-carboxylate clamp with the EEVD motif of Hsc70
are strictly conserved among homologous STI1 proteins (Fig.
1B, first alignment). In another alignment, we compared the
same basic residues in Hsc70-binding TPR domains of nonhomologous Hsc70-interacting proteins of colon cancer antigen
7 (NY-CO-7; Ref. 28), C terminus of Hsc70-interacting protein
(CHIP; Ref. 29), Hop (1), mSTI1 (4), human small glutaminerich protein (hSGT; Ref. 28), tetratricopeptide repeat domain 1
(TPR1; Ref. 28), tetratricopeptide repeat domain 2 (TPR2; Ref.
28), and Hsc70-interacting protein (Hip; Ref. 30). Conservation
was found to be less strict in these proteins, especially at
positions equivalent to Lys73 and Arg77 in Hop (Fig. 1B, second
alignment). As expected, the residues that are predicted to
determine specificity of binding to Hsc70 in Hop do not show
strict conservation when comparing functionally equivalent
Hsc70-interacting TPR domains (Fig. 1B, first and second
alignments). When comparing TPR1, TPR2A, and TPR2B domains of mSTI1, Ala49 and Lys50 in TPR1 are predicted to be
topologically equivalent to Phe270 and Glu271 in TPR2A, and
Thr405 and Lys406 in TPR2B, respectively (Fig. 1B, third alignment). Ala49 and Lys50 in Hop are predicted to be important in
determining Hsc70 binding specificity, whereas Phe270 and
Glu271 are predicted to be critical for the specific binding of
Hsp90 (6). Interestingly, TPR2B has similar specificity determinants at these positions to those of TPR1 (Ala49/Lys50
versus Thr405/Lys406), suggesting that it may have, yet to be
detected, Hsc70-interaction capacity (Fig. 1B, third alignment). Fig. 2 (A and B) shows the ribbon representations of
the crystal structures of the N- and C-terminal TPR domains
of Hop in complex with the C-terminal peptides of Hsp70 and
Hsp90, respectively. Amino acid residues involved in general
binding (Fig. 2A, i and ii) and specificity of binding (Fig. 2B,
i and ii) of the TPR domains to the peptides are represented
in sticks. Homology modeling, using co-ordinates generated
from Hop, revealed that the structures of the N- and
C-terminal TPR domains of mSTI1 are similar to that of Hop.
This is not unexpected because the two homologues share
97% amino acid identity.

Double Substitution of Lys8 and Asn12 in Helix A of the First
TPR Motif of mSTI1 Abrogated Specific Binding to Hsc70 —We
performed charged-to-alanine scanning mutagenesis of some of
the residues in mSTI1 that are predicted to be involved in
forming the so-called two-carboxylate clamp with the EEVD
sequence in Hsc70 and Hsp90. We generated single mutations:
GST-543 (K8A), GST-543 (N12A), GST-543 (N43A), GST-543
(K301A), and a double mutation, GST-543 (K8A,N12A), of the
full-length GST fusion protein (GST-543); and single mutations
GST-543 (⌬37– 47, K8A) and GST-543 (⌬37– 47, N12A) of the
deletion mutant GST-543 (⌬37– 47) (see “Experimental Procedures”). GST-543 (K73A), GST-543 (R77A), GST-543 (K229A),
and GST-543 (N233A) could not be produced successfully, possibly because of deleterious structural effects of the amino acid
substitutions on the protein. The various GST fusion proteins
were tested for their ability to bind to either Hsc70 from NIH
3T3 mouse fibroblast cell extracts or purified Hsp90. Our results showed that single mutation of Lys8 or Asn12 in helix 1A
of TPR1 had no significant effect on the specific binding of
mSTI1 to Hsc70, as these mutant proteins bound Hsc70 at
levels comparable with that of the unmodified protein (Fig. 3A,
lanes 1, 3, and 5). However, double mutation of Lys8 and Asn12,
GST-543 (K8A,N12A), abrogated binding to Hsc70 below detectable levels (Fig. 3A, lane 4). In contrast to Hsc70-mSTI1
interaction, single substitution of Lys301 in TPR2A, GST-543
(K301A), was found to abrogate binding of mSTI1 to Hsp90
(results not shown). Notably, mutation of Asn43 in helix 2A of
TPR1 led to a significant decrease in the affinity of mSTI1 for
Hsc70 but not abrogation (Fig. 3A, lane 7). As a negative
control (Fig. 3A, lane 6), we used a mutant GST derivative of
mSTI1, GST-543 (Y27A), which has been shown not to bind
Hsc70 (26). In all the binding assays, GST alone did not bind to
Hsc70 (Fig. 3).
To provide evidence that binding of Hsc70 to the GST-mSTI1
derivatives was specific and not the recognition of misfolded
proteins by Hsc70, we tested the sensitivities of the interactions to increasing ionic strength. The interaction of GST-543
appeared to be specific as binding of the unmodified protein
was found to decrease with increasing ionic concentrations
(result not shown). The binding of GST-543 (K8A), GST-543
(N12A), and GST-543 (N43A) followed the same pattern at
increasing ionic concentrations (results not shown). Single alanine substitution of Lys8 coupled with the deletion of a highly
conserved block in helix 2A of TPR1, GST-543 (⌬37– 47, K8A),
significantly lowered but did not abrogate binding of mSTI1 to
Hsc70 (Fig. 3B, lane 5). Similar result was obtained for the
GST-543 (⌬37– 47, N12A) mutant (result not shown). These
latter results corroborate earlier reports from our laboratory
(26). Taken together, these results showed that double substitution of Lys8 and Asn12 by alanine was required to abrogate
binding of mSTI1 to Hsc70, whereas single substitution of
Lys301 was sufficient to abrogate its binding to Hsp90.
Hsp90-binding Capacity Was Engineered on the Hsc70-binding TPR1 Domain of mSTI1—Based on the predictions from
the three-dimensional structure of the TPR domains of Hop in
complex with their respective peptides (6), we identified those
topologically equivalent residues involved in specificity determination that differed greatly, in TPR1 versus TPR2A, in the
nature of their contacts with residues upstream of the EEVD
motif of their respective Hsps. We observed that Tyr236, Phe270,
and Glu271 in TPR2A are significantly different from but topologically equivalent to Leu15, Ala49, and Lys50 respectively, in
TPR1 (Fig. 2B). We reasoned that by doing simple amino acid
substitutions of L15Y, A49F, and K50E, and Y236L, F270A,
and E271K, we could swap the binding specificity of TPR1 and
TPR2A domains, respectively. Theoretically, these substitu-
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FIG. 1. TPR domain organization in mSTI1 and multiple sequence alignment of TPR domains from Hsc70-interacting proteins. A,
schematic representation of GST-mSTI1 derivatives showing the GST tag (large solid bars), mSTI1 sequence (large open bars), TPR motifs (small
open bars), and TPR domains (as indicated on grid). The numbering refers to amino acid positions in mSTI1. B, multiple sequence alignment of
Hsc70-interacting TPR domains of STI1. Helices A and B of each TPR motif are shown beneath the alignment (dashed lines), whereas the complete
TPR motifs are represented as horizontal bars. Residues that are predicted to form a two-carboxylate clamp with the terminal aspartate in Hsc70
are highlighted in black, whereas asterisk (*) indicates positions of residues predicted to determine specificity of binding. A highly conserved block
of residues in the second TPR motif is shown in unfilled box. Hsc70-binding TPR1 domains of STI1 homologues: rn (Rattus norvegicus,
CAA75351.1), m (Mus musculus, AAC53267.1), cg (Cricetulus griseus, AAB94760.1), h (Homo sapiens, AAA58682.1), tc (Trypanosoma cruzi,
AAC97378.1), ac (Achantamoeba castellanii, AAB49720), at (Arabidopsis thaliana, CAB45987.1), gm (Glycine max, S56658), dm (Drosophila
melanogaster, AAC12945.1), lm (Leishmania major, AAB37318), sp (Schizosaccharomyces pombe, CAB39910.1), sc (Saccharomyces cerevisiae,
CAA60743.1). TPR1 domains of Hsc70-interacting proteins: NY-CO-7 (colon cancer antigen 7, AAC18038), CHIP (C terminus of Hsc70-interacting
protein, AAK61242), hSTI1 (human STI1 or Hop, AAA58682.1), mSTI1 (murine STI1 or extendin, AAC53267.1), hSGT (human small glutaminerich protein, NP_003012), TPR1 (tetratricopeptide repeat domain 1, NP_003305), TPR2 (tetratricopeptide repeat domain 2, NP_003306), and Hip
(Hsc70-interacting protein, P50502). Alignment of TPR1, TPR2A, and TPR2B domains of mSTI1 was as follows: TPR1, N-terminal TPR domain
of mSTI1; TPR2A, first central TPR domain of mSTI1; and TPR2B, second central TPR domain of mSTI1.

tions should allow TPR1 to accommodate Met⫺4 of Hsp90 and
TPR2A to accommodate Ile⫺4 of Hsc70, respectively. We therefore proposed, first, that L15Y, A49F, and K50E substitutions
in TPR1 domain of mSTI1 would result in loss of ability to bind

Hsc70 and gain of capacity to bind Hsp90, and second, that
Y236L, F270A, and E271K substitutions in TPR2A would result in loss of ability to bind Hsp90 and gain of capacity to bind
Hsc70. In the first part of our hypothesis, we generated single,

6900

Hsc70-mSTI1 Interaction

double, and triple mutants using the C-terminal truncated
mutant protein GST-N217 (TPR2A and TPR2B domains removed) as follows: GST-N217 (L15Y), GST-N217 (A49F,K50E),
and GST-N217 (L15Y,A49F,K50E). These modified proteins
were tested for their ability to bind both Hsc70 and Hsp90. In
the Hsc70 co-precipitation assays, GST-N217 was found to
associate with Hsc70 at levels that compared favorably with
the full-length protein, GST-543 (Fig. 4A, lanes 1 and 3). As
expected, both GST-543 (Y27A) and GST did not bind to Hsc70
(Fig. 4A, lanes 2 and 4). The single mutant GST-N217 (L15Y)
bound to Hsc70 at a slightly lower level compared with GSTN217, whereas binding was significantly lowered using the
double mutant GST-N217 (A49F,K50E) (Fig. 4A, lanes 5 and
6). No binding to Hsc70 was observed in the triple mutant
GST-N217 (L15Y,A49F,K50E) (Fig. 4A, lane 7). We thus concluded that double substitution of Ala49 and Lys50 in mSTI1
drastically reduced binding to Hsc70, whereas triple substitution of Leu15, Ala49, and Lys50 abolished binding. The next step
was to test whether these mutants could interact with Hsp90.
In this experiment, we used purified Hsp90 instead of cell
lysates. As expected, both full-length unmodified protein GST543 and N-terminal truncated protein GST-C334 (TPR1 domain deleted) bound to purified Hsp90 at equivalent levels
(Fig. 4B, lanes 1 and 3). Additionally, the C-terminal truncated
protein GST-N217, its mutant derivative GST-N217 (L15Y)
and GST alone did not bind to Hsp90 as expected (Fig. 4B,

FIG. 2. Hop TPR domains in complexes with C-terminal Hsc70
and Hsp90 peptides. Ribbon representations of the crystal structures
of the N-terminal TPR (TPR1; Protein Data Bank code 1ELW) and
central TPR (TPR2A; Protein Data Bank code 1ELR) domains of Hop in
complexes with the C-terminal heptapeptide of Hsp70 and pentapeptide of Hsp90, respectively. TPR domains are shown as ribbons, peptides as rods, and amino acid residues as sticks. The TPR residues are

labeled by the single-letter code and a number that relates to its position
in the primary amino acid sequence. A, basic residues in TPR domains
of Hop form a network of electrostatic interactions with terminal aspartate (Asp0) in Hsp70 (i). Hsp90 binds to the central TPR domain
(TPR2A) of Hop by a similar mechanism (ii). B, specificity of binding is
determined by hydrophobic contacts with Ile⫺4 in Hsp70 (i) and Met⫺5
in Hsp90 (ii). The panels were drawn using MOLSCRIPT (32).
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FIG. 3. Hsc70-mSTI1 interaction is differentially perturbed by
substitution of residues in mSTI1 predicted to be important for
binding to Hsc70. GST-mSTI1 fusion proteins (0.3 M) previously
coupled to glutathione-agarose beads were incubated with 250 g of
extracts of NIH 3T3 mouse fibroblasts for 2 h at 4 °C. The beads were
washed extensively to remove unbound proteins. Bound proteins were
solubilized in SDS sample buffer and separated by 12% SDS-PAGE.
After transferring onto nitrocellulose membrane, co-precipitation of
Hsc70 with the GST-mSTI1 fusion proteins was revealed by immunodetection and chemiluminescent autoradiography. 543 is equivalent to
GST-543 as described under “Experimental Procedures.” Information in
brackets indicates mutations carried out in the proteins.
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lanes 2, 4, and 6). Interestingly, the double mutant GST-N217
(A49F,K50E) was found to bind to Hsp90 at levels comparable
with both GST-543 and GST-C334 (Fig. 4B, lane 5). Surprisingly, no Hsp90 binding was observed with the triple mutant
GST-N217 (L15Y,A49F,K50E) (Fig. 4B, lane 7). Put together,
these results suggested that double mutation of Ala49 and
Lys50 by Phe and Glu, respectively, was sufficient to confer the
ability to bind Hsp90 on the Hsc70-binding TPR1 domain of
mSTI1.
Hsc70-binding Capacity Could Not Be Engineered onto the
TPR2A Domain—We used the N-terminal truncated mutant
protein GST-C334, incapable of binding to Hsc70, to generate
the following modified proteins: GST-C334 (Y236L), GST-C334
(F270A,E271K), and GST-C334 (Y236L,F270A,E271K) and
tested them for their ability to bind to both Hsp90 and Hsc70.
Both GST-543 and GST-C334 were found to bind Hsp90 as expected (Fig. 5A, lanes 1 and 6). GST did not bind to Hsp90 (Fig.
5A, lane 2). Interestingly, the single, double, and triple mutant
proteins, GST-C334 (Y236L), GST-C334 (F270A,E271K), and
GST-C334 (Y236L,F270A,E271K), respectively, lost their ability
to bind to Hsp90 (Fig. 5A, lanes 3, 4, and 5). Next, the proteins
were tested for their ability to bind to Hsc70. GST-543 was found
to bind to Hsc70 successfully, whereas GST did not (Fig. 5B,
lanes 1 and 2). None of the GST-C334 mutants were able to bind
to Hsc70 (Fig. 5B, lanes 3, 4, and 5). These results indicated that
single mutation of any of the residues in TPR2A that make
hydrophobic contacts with the C-terminal peptide of Hsp90 abrogated binding of mSTI1 to Hsp90. In addition, engineering
Hsc70-binding capacity on TPR2A was not possible by simple
swapping of topologically equivalent residues.
Hsc70 Potentially Makes Contact with mSTI1 outside the
N-terminal TPR Domain—Steady-state fluorescence and circular dichroism spectroscopies were used to analyze the effects of
mutations on both the secondary (far- and near-UV) and tertiary structures (steady-state fluorescence) of the His6-tagged
mSTI1 proteins. The intrinsic fluorescence of the lone trypto-

FIG. 5. Hsc70-binding capacity could not be engineered onto
the Hsp90-binding TPR2A of mSTI1. GST-mSTI1 fusion proteins
(0.3 M) previously coupled to glutathione-agarose beads were incubated with purified Hsp90 (0.025 M; A) or 250 g of extracts of NIH
3T3 mouse fibroblasts (B) for 2 h at 4 °C. Further steps were the same
as described in Fig. 3. 543 is equivalent to GST-543 and C334 to
GST-C334 as described under “Experimental Procedures.” Information
in brackets indicates mutations carried out in the proteins.

phan in mSTI1 (Trp71) was monitored. This tryptophan is
located in helix B of the second TPR motif, a position in relatively close proximity to the regions of the mutations, and
therefore could serve effectively as a local probe. Notable results were obtained with the His6-tagged double mutant, His543 (K8A,N12A). The fluorescence profile of the wild type protein (His-543) showed a characteristic peak at 345 nm (Fig. 6A),
indicative of a partially buried residue. Completely exposed
residues give a wavelength peak in the vicinity of 357 nm. The
fluorescence profile of the His-543 (K8A,N12A) mutant revealed an identical peak wavelength at 345 nm with a slight
increase in intensity. This indicated a similar environment
surrounding the tryptophan residue in both proteins and suggested that there was no significant change in the tertiary
structure of the TPR1 domain resulting from the mutations.
Interestingly however, both far- and near-UV circular dichroisms revealed an apparent loss of helical content in the His-543
(K8A,N12A) variant protein. This was illustrated by the decrease in ellipticity observed in the spectra of the double mutant protein (Fig. 6B). Together, these results suggested that
the apparent loss of helical content might have occurred in
other parts of the protein that interact with the N-terminal
TPR domain and make contact with Hsc70 upon binding.
Quantitative Analysis of mSTI1-Hsc70 Interactions—To determine the contribution of each individual amino acid residue
to the binding of Hsc70 by mSTI1, we used surface plasmon
resonance spectroscopy to monitor bimolecular interactions.
Unmodified mSTI1 and its mutants were immobilized on biosensor chip equilibrated with buffer A. GST was bound to a
reference flow cell and used as a control. Subsequently, increasing concentrations of full-length Hsc70 and Hsp90 were then
passed over the chip and binding of the proteins was monitored
(Figs. 7 and 8). Thermodynamic dissociation constants (KD
values) were determined and taken as apparent affinities of
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FIG. 4. Hsp90-binding capacity was engineered on the Hsc70binding TPR1 domain of mSTI1. GST-mSTI1 fusion proteins (0.3
M) previously coupled to glutathione-agarose beads were incubated
with 250 g of extracts of NIH 3T3 mouse fibroblasts (A) or purified
Hsp90 (0.025 M; B) for 2 h at 4 °C. Further steps were the same as
described in Fig. 3. 543 is equivalent to GST-543, N217 to GST-N217,
and C334 to GST-C334 as described under “Experimental Procedures.”
Information in brackets indicates mutations carried out in the proteins.
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DISCUSSION

FIG. 6. Double substitution of Lys8 and Asn12 in mSTI1 potentially perturbed contacts made outside the TPR1 domain. A,
steady-state fluorescence using the lone tryptophan (Trp71) in His-543
(open circles) and His-543 (K8A,N12A) (closed circles). Excitation was
done at 295 nm wavelength. B, far-UV circular dichroism spectra of
His-543 (open circles) and His-543 (K8A,N12A) (closed circles) in 20 mM
sodium phosphate buffer, pH 7.5. Spectra are an average of 10 runs.
The inset describes the near-UV dichroism spectra of His-543 (open
circles) and His-543 (K8A,N12A) (closed circles) in the same buffer.

binding. However, it should be noted that the kinetics of binding could not be fitted perfectly to a 1:1 Langmuir binding
model. The KD of the binding of unmodified mSTI1 protein to
Hsc70 was calculated to be ⬃2 M (Fig. 7A). Generally, the KD
values of the mutant mSTI1 proteins were significantly higher
than that of the unmodified mSTI1, indicating reduced binding
affinities (Fig. 7B). It is notable that most of the mutants
displayed predominantly rapid kinetics (Fig. 7B). In the Hsp90
binding assays, the unmodified mSTI1 (543; Fig. 8) displayed
kinetics similar to its interaction with Hsc70 and the KD was
calculated to be 1.5 M. These KD values are similar to earlier
reports (21). A very interesting observation was the higher affinity of the N217 (A49F,K50E) mutant protein, KD of 0.15 M,
compared with the wild type protein. Interestingly, even in the
presence of Hsc70, the protein was still able to bind to Hsp90 to
the same affinity (Fig. 8B). From these results we can conclude
that mutation of any of the residues in TPR1 of mSTI1 that form
the so-called two-carboxylate clamp reduces its affinity to bind to
Hsc70 and that the individual amino acid residues contribute
differentially to the network of electrostatic contacts.

Based on mutational analyses, the Hsc70 and Hsp90 interacting domains of Hop and mSTI1 have been mapped to their
N- and C-terminal TPR domains, respectively (3, 5, 6, 26). We
have shown that the amino acid residues 1–109 in the Nterminal TPR domain in mSTI1, without extensive flanking
regions, are necessary and sufficient for its interaction with
Hsc70 (26). In addition, our results suggested that the consensus residue Tyr27 in the first TPR motif of mSTI1 might play a
crucial structural role by holding charged residues in the first
TPR motif in position for interaction with complementary
charged groups of Hsc70. The crystal structure of the TPR1
domain of Hop in complex with C-terminal Hsp70 heptapeptide
predicts that certain basic residues protruding into the TPR
groove are required for its interaction with Hsp70 (6). Furthermore, the structure suggests that hydrophobic contacts are
critical in determining specificity of binding of Hop to Hsp70.
We have further characterized these interactions both qualitatively and quantitatively, in an mSTI1-Hsc70 model.
Among the residues in Hop predicted to be required for
formation of a critical two-carboxylate clamp with the C-terminal aspartate (Asp0) of the Hsp70 peptide are Lys8, Asn12,
Asn43, Lys73, and Arg77 (6). Multiple sequence alignments (Fig.
1B) revealed that Lys8, Asn12, and Asn43 are strictly conserved
in Hsc70-interacting TPR motifs including those from nonhomologous proteins. Except for Hip, all these proteins interact
with Hsc70 via its C-terminal EEVD motif (28). The side chains
of Lys8 and Asn12 were proposed to form direct hydrogen bonds
with the C-terminal main-chain carboxylate of Asp0 in Hsp70
(6). Although co-precipitation assays indicated that mutation of
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FIG. 7. Binding affinities of mSTI1 and its mutants to Hsc70. A,
Hsc70 was titrated against GST-543 using surface plasmon resonance
spectroscopy to determine binding affinity. Experiments were performed at 25 °C in PBS containing 0.005% P20 surfactant. Approximately 700 response units of GST-543 fusion protein were immobilized
on a sensor chip CM5 on which anti-GST was previously attached via
amine coupling to carboxymethylated dextran. Increasing concentrations of Hsc70 were injected at a flow rate of 10 l/min. Recombinant
GST was immobilized on a reference flow cell, and background binding
to GST was subtracted from each signal. B, relative binding response
curves of GST-543 and its mutants to Hsc70 (8 M).
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these residues singly to alanine did not significantly affect
binding of mSTI1 to Hsc70, surface plasmon resonance spectroscopy revealed a significant reduction in the binding affinities of the mutant proteins to Hsc70. The SPR results may be
regarded as being more reliable because the technique is both
quantitative and highly sensitive compared with co-precipitation assays. However, both assays revealed that double mutation of these residues to alanine abrogated binding of mSTI1 to
Hsc70. In addition to these, results from steady-state fluorescence and circular dichroism spectroscopies strongly suggested
that these mutations in mSTI1 might have caused perturbations in parts of the protein outside the TPR1 domain, resulting
in loss of helical content. Hence, the observed abrogation of
binding to Hsc70 might have occurred primarily as a result of
loss of important electrostatic contacts with the TPR domain
and secondarily as a result of disruption of contacts with other
domains required for complete interaction with Hsc70. Support
for this hypothesis comes from earlier observation that mutation of the C-terminal DPEV motif of Hop or its DPAM to APAV
and APAM, respectively, caused a reduction in the ability of
Hop to bind to Hsp70 (31). This is a very interesting phenomenon because truncation of this region from Hop caused only a
partial loss in Hsp70 binding (5). In a helix-rich protein such as
mSTI1, it is most likely that this C-terminal region of the
protein folds into a helical structure. Of interest, however, is
the observation that binding of Hop to Hsp90 was unaffected by
mutations in this region (31). Therefore, we conclude that the
collective electrostatic contacts made by Lys8 and Asn12 in
TPR1 domain of mSTI1 define part of the minimum critical
contacts necessary for successful binding to Hsc70 but for complete and tight ligand binding other contacts outside the TPR
domain are required.
Mutation of Asn43 to alanine significantly lowered but did
not abrogate mSTI1-Hsc70 interaction. Asn43 occurs within
helix A of the second TPR motif (helix 2A), a region that is
highly conserved in homologous STI1 TPR domains. Deletion of
this highly conserved block of amino acid residues coupled with

the mutation of Lys8 or Asn12 alone to alanine significantly
lowered but did not abrogate binding of mSTI1 to Hsc70. This
result is consistent with and extends our earlier report that
removal of the highly conserved part of helix 2A lowered but
did not abolish binding of mSTI1 to Hsc70 (26). It is possible
that there is a shifting of the helices to compensate for the loss
of helix 2A. The side-chain carbonyl of Asn43 makes a direct
hydrogen bond contact with the backbone amide of Asp0 of
Hsc70, and an indirect contact with the side-chain carboxylate
of the same residue that is mediated by a tightly bound water
molecule. The interactions of Asn43 and other helix 2A residues
appear not to be as important for Hsc70 binding as the electrostatic contacts made collectively by Lys8 and Asn12 with Asp0.
Our results, which are partially consistent with crystallographic predictions for the Hop-Hsp70 peptide complex, suggested that a network of electrostatic interactions was necessary for the binding of mSTI1 to Hsc70. In addition, our results
suggested that electrostatic interactions involving residues in
the first TPR motif (Lys8 and Asn12) might be more critical for
successful mSTI1-Hsc70 interaction than those electrostatic
interactions involving residues in the second TPR motif
(Asn43). Interestingly, however, single substitution of Lys301 in
the central TPR domain of mSTI1 caused an abrogation of its
interaction with Hsp90. We can infer from these observations
that, even though the mechanisms of binding of TPR1 and
TPR2A domains of mSTI1 or Hop to their respective peptides
look similar, they are not exactly identical.
The crystal structures of the Hop TPR domains in complex
with Hsp70 and Hsp90 peptides predict that certain residues in
Hop make hydrophobic and van der Waals contacts with residues in the peptides, and that these interactions discriminate
between the C termini of Hsp70 and Hsp90. Based on these
data and sequence alignments, we hypothesized that by doing
L15Y, A49F, and K50E substitutions, we could engineer TPR1
to accommodate the Met⫺4 upstream of the Hsp90 C-terminal
EEVD motif and hence bind Hsp90 with high affinity. Conversely, by doing Y236L, F270A, and E271K substitutions in
TPR2A, we hypothesized that we could engineer this domain to
bind to Hsc70. For the first hypothesis, we used a C-terminal
truncated GST fusion derivative of mSTI1, GST-N217, that
lacks the Hsp90-binding TPR domain. As expected, the L15Y
substitution alone only slightly lowered the affinity of mSTI1
for Hsc70. However, GST-N217 (L15Y) did not bind to Hsp90.
This observation may be the result of the fact that substituting
Tyr for Leu did not provide enough hydrophobic contacts for the
mutant mSTI1 to interact successfully with Hsp90. Interestingly, the double mutant GST-N217 (A49F,K50E) bound to
Hsc70 with low affinity, whereas it successfully bound to
Hsp90 with an affinity even higher than that of the full-length
unmodified protein, as indicated by SPR spectroscopy. Therefore, substitution of Ala49 and Lys50 to Phe and Glu, respectively, in mSTI1 resulted in drastic loss of ability to bind Hsc70
but gain of ability to bind Hsp90 with high affinity. Surprisingly, the triple mutant GST-N217 (L15Y,A49F,K50E) lost
ability to bind to both Hsc70 and Hsp90. Although Leu15 may
be involved in specificity, its proximity to Lys8 and Asn12 may
suggest that any changes in this region will disturb the twocarboxylate clamp sufficiently to cause the triple mutant GSTN217 (L15Y,A49F,K50E) to lose its capacity to bind to Hsp90.
For the second hypothesis, we used an N-terminal truncated
GST fusion derivative of mSTI1 (GST-C334), which lacks the
Hsc70-binding TPR domain. All three modified proteins, GSTC334 (Y236L), GST-C334 (F270A,E271K), and GST-C334
(Y236L,F270A,E271K), could not bind to either Hsc70 or
Hsp90. These results suggest that binding of Hsc70 to mSTI1
or Hop is more specific than the binding of Hsp90 with serious
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FIG. 8. Binding affinities of mSTI1 and its mutants to Hsp90. A,
Hsp90 was titrated against GST-543 using surface plasmon resonance
spectroscopy to determine binding affinity. Experiments were performed as described in Fig. 7. B, relative binding response curves of
GST-543 and its mutants to Hsp90 (5 M).
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implications for the sequential interaction of mSTI1 or Hop to
Hsc70 and Hsp90 in vivo. It has been reported recently that the
affinity of Hsp70 for Hop increases in the presence of Hsp90
and that Hsp90 reduces the number of Hsp70 binding sites on
the Hop dimer (33).
In conclusion, first, we have provided evidence to show that
hydrophobic contacts in the second TPR motif (Ala49 and Lys50)
of TPR1 may be more important than other regions of this
domain in determining specificity of mSTI1 interaction with
Hsc70. Second, we have successfully engineered Hsp90 binding
capacity on the TPR1 domain of mSTI1 by doing simple amino
acid substitutions without elaborate “domain swapping.”
Third, we have shown that the mechanisms of interaction of
mSTI1 with Hsc70 and Hsp90 are not identical. Although our
data further the understanding of the molecular basis of the
interaction of mSTI1/Hop with Hsc70 and Hsp90, more mutagenesis studies and the three-dimensional structures of
mSTI1/Hop in complex with full-length Hsc70 and Hsp90 are
needed for a more complete understanding of the mechanisms
of interaction.
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